Yongling Tu
Westat
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yongling Tu.
Transfusion | 2005
Simone A. Glynn; David Wright; Steven H. Kleinman; Dale F. Hirschkorn; Yongling Tu; Charles M. Heldebrant; Richard Smith; Cristina Giachetti; James Gallarda; Michael P. Busch
BACKGROUND: It is important to characterize viral dynamics in early hepatitis C virus (HCV) infection to further our understanding of viral pathogenesis and the potential for secondary transmission in acute infection through blood transfusion or other routes.
Transfusion | 2006
George B. Schreiber; Karen S. Schlumpf; Simone A. Glynn; David Wright; Yongling Tu; Melissa King; Martha J. Higgins; Debra Kessler; Ronald O. Gilcher; Catharie C. Nass; Anne M. Guiltinan
BACKGROUND: To prevent donor loss and improve retention, it is important to understand the major deterrents to blood donation and to identify factors that can be effectively addressed by blood centers.
Transfusion | 1999
Helen E. Ownby; F. Kong; K. Watanabe; Yongling Tu; Catharie C. Nass
BACKGROUND: Efforts to provide a safe, adequate blood supply have been inhibited by persistent shortages attributed to a lack of motivation on the part of the general public and inefficiency in recruiting processes. This study examined whether frequency of donations and/or timing of subsequent donations by first‐time donors related to donor demographics.
Transfusion | 2007
Whitney R. Steele; George B. Schreiber; Anne M. Guiltinan; Catharie C. Nass; Simone A. Glynn; David Wright; Debra Kessler; Karen S. Schlumpf; Yongling Tu; James W. Smith; George Garratty
BACKGROUND: Blood donation can be described as a prosocial behavior, and donors often cite prosocial reasons such as altruism, empathy, or social responsibility for their willingness to donate. Previous studies have not quantitatively evaluated these characteristics in donors or examined how they relate to donation frequency.
Vox Sanguinis | 2005
George B. Schreiber; U. K. Sharma; David J. Wright; S. A. Glynn; Helen E. Ownby; Yongling Tu; George Garratty; Jane Allyn Piliavin; T. Zuck; R. Gilcher
Background and Objectives Converting first‐time donors to become regular donors continues to be a challenge facing blood centres. We examined whether first‐time donors with frequent return in the first 12 months were more likely to become regular donors.
Transfusion | 2007
Karen S. Schlumpf; Simone A. Glynn; George B. Schreiber; David Wright; Whitney R. Steele; Yongling Tu; Sigurd Hermansen; Martha J. Higgins; George Garratty; Edward L. Murphy
BACKGROUND: To predict future blood donation behavior and improve donor retention, it is important to understand the determinants of donor return.
Transfusion | 2006
Simone A. Glynn; George B. Schreiber; Edward L. Murphy; Debra Kessler; Martha J. Higgins; David Wright; Sunitha Mathew; Yongling Tu; Melissa King; James W. Smith
BACKGROUND: Understanding factors that encourage different racial and ethnic groups to donate is crucial for donor recruitment and retention.
Transfusion | 2007
Marc Germain; Simone A. Glynn; George B. Schreiber; Stéphanie Gélinas; Melissa King; Michael Jones; James Bethel; Yongling Tu
BACKGROUND: There is a need to identify factors explaining why some people stop donating blood.
Transfusion | 2005
Michael P. Busch; Simone A. Glynn; David Wright; Dale F. Hirschkorn; Megan E. Laycock; Joan D. McAuley; Yongling Tu; Cristina Giachetti; James Gallarda; John W. Heitman; Steven H. Kleinman
BACKGROUND: Screening donors for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) RNA is primarily performed on minipools (MPs) with one of two commercial nucleic acid amplification tests (NAT; Roche Molecular Systems; or Gen‐Probe/Chiron). We compared these assays with respect to detection of RNA in early HIV and HCV infection.
Transfusion | 2001
Usha Sharma; George B. Schreiber; Simone A. Glynn; Catharie C. Nass; Martha J. Higgins; Yongling Tu; Jim Bethel; Alan E. Williams
BACKGROUND : Increased knowledge of HIV transmission and behavioral and test screening may encourage high‐risk blood donors to self‐defer.